本文へ移動
cccskills
無料GitHub で公開

es-cushing-initial-resection-recommendation

Recommends initial surgical resection of the primary lesion(s) causing Cushing's syndrome when surgery is feasible and likely to significantly reduce glucocorticoid excess. Trigger phrases include overt Cushing's syndrome, ACTH-dependent CS, ectopic ACTH secretion, adrenal adenoma, bilateral macronodular adrenal hyperplasia, and persistent hypercortisolism.

dromlakhani/MD2SKILL
インストール方法を見る

含まれるファイル（1）

  • SKILL.md2.8 KB

SKILL.md（原文）

インストールする前に、エージェントに与えられる指示の中身を確認できます。

Initial Resection of Primary Lesion(s) for Cushing's Syndrome

STEP 1 — Gather Information

Confirm overt Cushing's syndrome via abnormal cortisol excretion (UFC, late-night salivary cortisol, dexamethasone suppression) and determine etiology: pituitary MRI for ACTH-secreting tumor, chest/abdominal imaging for ectopic source, adrenal CT/MRI for adrenal lesion; assess surgical feasibility and likelihood of significant glucocorticoid reduction.

STEP 2 — Rule In / Rule Out

Is surgery possible and likely to significantly reduce glucocorticoid excess? If no, proceed to second-line therapies (medication, bilateral adrenalectomy, radiation). If yes, move to classification.

STEP 3 — Classify or Stratify

Classify by etiology: pituitary Cushing's disease -> transsphenoidal selective adenomectomy (TSS); ectopic ACTH-secreting tumor -> localization and resection with node dissection; benign unilateral adrenal adenoma/carcinoma -> unilateral adrenalectomy; bilateral macronodular adrenal hyperplasia (BMAH) -> consider bilateral adrenalectomy if aberrant hormone receptors demonstrated, otherwise medical therapy; adrenal carcinoma -> resection if resectable, else consider adjuvant therapy.

STEP 4 — Decide

Perform the indicated primary lesion resection by an experienced surgeon (adrenal, pituitary, or thoracic/abdominal as appropriate) with goal of normalizing cortisol levels or action.

Clinical Guardrails / Mimics / Pitfalls

Do not resort to surgery if it is unlikely to significantly reduce glucocorticoid excess (e.g., diffuse ectopic disease, unresectable carcinoma); avoid mistaking ectopic source for pituitary lesion without proper localization; ensure surgeon expertise to minimize complications; do not proceed with bilateral adrenalectomy for BMAH without evidence of aberrant receptor coupling; monitor for postoperative adrenal insufficiency and provide glucocorticoid replacement as needed.

Concrete Clinical Example

A 48-year-old man presents with overt Cushing's syndrome, elevated UFC and loss of diurnal rhythm; pituitary MRI reveals 8 mm microadenoma, inferior petrosal sinus sampling confirms central ACTH source; he undergoes transsphenoidal selective adenomectomy by an experienced pituitary surgeon; postoperative morning cortisol normalizes within 2 weeks, achieving remission.

Source: Treatment of Cushing’s Syndrome: An Endocrine Society Clinical Practice Guideline, Nieman et al., 2015, DOI:10.1210/jc.2015-1818

レビュー

まだレビューはありません。使ってみた感想をお寄せください。

ログインしてレビューを書く

同じリポジトリのスキル

概要と使いどころ

780g-pump-adjustment

無料

Guide pump setting adjustments for the MiniMed 780G system based on CareLink data, using Medtronic's 3-step follow-up workflow. Use when a clinician has CareLink data for a 780G patient and wants to know what to change — which setting, by how much, and how to program it. Triggers include: "what do I adjust", "how to fix high TIR", "how to reduce hypos", "adjust ICR/ISF/basal", "SmartGuard settings", "780G pump settings review", or any question about optimising 780G therapy after reviewing a download.

日本語の概要は準備中です。原文の説明を表示しています。

dromlakhani/MD2SKILL122026年10月5日 更新

ata-acth-stim-test-interpretation

無料

Performs corticotropin stimulation test to diagnose adrenal insufficiency when morning cortisol is indeterminate (3-15 µg/dL). Triggers include morning cortisol 3-15 µg/dL requiring further AI testing.

日本語の概要は準備中です。原文の説明を表示しています。

dromlakhani/MD2SKILL122026年10月5日 更新

ata-adrenal-crisis-treatment

無料

Administers immediate parenteral injection of 50–100 mg hydrocortisone for suspected adrenal crisis secondary to adrenal insufficiency. Triggers include hypotension, hypoglycemia, or acute illness in a patient with known adrenal insufficiency.

日本語の概要は準備中です。原文の説明を表示しています。

dromlakhani/MD2SKILL122026年10月5日 更新

ata-aed-ai-education

無料

Clinicians educate adrenal insufficiency patients taking nondexamethasone glucocorticoids who initiate enzyme-inducing antiepileptic drugs about early signs of adrenal insufficiency. Trigger when an AI patient on nondexamethasone GC starts an enzyme-inducing AED such as phenytoin, carbamazepine, or oxcarbazepine.

日本語の概要は準備中です。原文の説明を表示しています。

dromlakhani/MD2SKILL122026年10月5日 更新

ata-aed-lt4-monitoring

無料

In central hypothyroidism patients receiving levothyroxine who initiate enzyme‑inducing antiepileptic drugs, the guideline recommends checking free T4 at least 6 weeks after AED start and increasing the levothyroxine dose if free T4 falls below the target range. Triggers include: central hypothyroidism patient on levothyroxine starting antiepileptic drug such as phenytoin, carbamazepine, or oxcarbazepine.

日本語の概要は準備中です。原文の説明を表示しています。

dromlakhani/MD2SKILL122026年10月5日 更新

ata-cortisol-cutoff-ai-diagnosis

無料

Applies serum cortisol cutoffs (<3 μg/dL indicates central adrenal insufficiency; >15 μg/dL likely excludes it) when evaluating morning cortisol for suspected adrenal insufficiency. Triggers include morning cortisol measurement in suspected AI and use when interpreting morning cortisol levels for adrenal insufficiency workup.

日本語の概要は準備中です。原文の説明を表示しています。

dromlakhani/MD2SKILL122026年10月5日 更新

dromlakhani のスキルをすべて見る

このスキルの問題を報告する